Recent Posts
- A072301: Phase III trial of radiotherapy followed by adjuvant temozolomide in combination with the IDH inhibitor vorasidenib vs. placebo in IDH-mutated newly-diagnosed grade 3 astrocytomas (NCT07215910)
- BGB-43395-302 (KANDELA-302)
- LITESPARK-033 (MK6482-033)
- HN015: A Phase II Randomized Trial of Neoadjuvant Chemotherapy or Chemo-Immunotherapy in Patients with Recurrent/Persistent PD-L1 Enriched Squamous Cell Carcinoma of the Head and Neck Undergoing Salvage Surgery (NEOPOLIS) (NCT07195734)
- GY037: A Phase III study of induction pembrolizumab and chemotherapy followed by chemoradiation and pembrolizumab versus chemoradiation and pembrolizumab both followed by pembrolizumab for high risk locally advanced cervical cancer (NCT04158141)
Recent Comments
No comments to show.


